SynthesisDiabetes, obesity & metabolism2021

Meta-analysis of the hallmark cardiovascular and renal outcome trials addressing the risk for respiratory tract infections with sodium-glucose co-transporter-2 inhibitors: Implications for the COVID-19 pandemic.

Dimitrios Patoulias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.